雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Aging-related frailty and sarcopenia. Frailty - Sarcopenia and biomarker. Inoue Aiko 1 , Kuzuya Masafumi 2 , Cheng Xianwu 3 1Institutes of Innovation for Future Society, Nagoya University, Japan. 2Institutes of Innovation for Future Society, Nagoya University/Department of Community Healthcare and Geriatrics, Nagoya University Graduate School of Medicine, Japan. 3Institutes of Innovation for Future Society, Nagoya University, Japan/Department of Cardiology and Hypertension, Yanbian university Hospital, Yanji, Chaina. pp.1191-1200
Published Date 2018/8/28
DOI https://doi.org/10.20837/42018091191
  • Abstract
  • Look Inside
  • Reference

 Frailty is an aging-related medical syndrome which contains the decline in physiological, cognitive, and social reserves abilities. It has been known to be important to early identify and prevent reversible frailty. On the other hand, sarcopenia, the aging-related loss of muscle mass and strength or function is major determinant of the quality of life of elderly and frailty. Recently, the accumulating evidence of the physical frailty concept suggested that it is as a risk factor for the long-term care, leading to be important to extend the healthy lifespan. However, the diagnosis of frailty is not necessarily unified, the molecular mechanism underlying the onset of sarcopenia is not clear, and clinical treatment strategy has not been established. Therefore, the searching and identifying of the biomarkers of the frailty and sarcopenia is very important for the prevention as well as the treatment of the muscle disease, and the further studies will be needed to investigate these issues.



基本情報

電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有